Structural basis of conformational variance in phosphorylated and non-phosphorylated states of PKCβII.

about

Structural basis of conformational variance in phosphorylated and non-phosphorylated states of PKCβII.

Item

http://www.wikidata.org/entity/Q55072903

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Structural basis of conformati ...... osphorylated states of PKCβII.

@en

Structural basis of conformati ...... osphorylated states of PKCβII.

@nl

type

Item

label

Structural basis of conformati ...... osphorylated states of PKCβII.

@en

Structural basis of conformati ...... osphorylated states of PKCβII.

@nl

prefLabel

Structural basis of conformati ...... osphorylated states of PKCβII.

@en

Structural basis of conformati ...... osphorylated states of PKCβII.

@nl

P1476

Structural basis of conformati ...... osphorylated states of PKCβII.

@en

P2093

Baljinder K Grewal

http://www.w3.org/2001/XMLSchema#string

M Elizabeth Sobhia

http://www.w3.org/2001/XMLSchema#string

R Venkata Krishnan

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase

Dynamic features of cAMP-dependent protein kinase revealed by apoenzyme crystal structure

Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase

Structures of the PKC-iota kinase domain in its ATP-bound and apo forms reveal defined structures of residues 533-551 in the C-terminal tail and their roles in ATP binding

Crystal Structure and Allosteric Activation of Protein Kinase C βII

Crystal structure of the tyrosine kinase domain of the human insulin receptor

VMD: visual molecular dynamics

The conformational plasticity of protein kinases

Development and testing of a general amber force field

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

P304

1332-1347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROT.24500

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259493618

http://www.w3.org/2001/XMLSchema#string

P698

25050443

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation